Chapter 20: The Kidney: Pathology and Disease

The Kidney: Pathology and Disease exploration of renal pathology details the complex physiological and structural mechanisms governing kidney health and the systemic consequences of its dysfunction. It begins by categorizing renal disorders through their primary impact on four anatomical targets: the glomeruli, tubules, interstitium, and blood vessels, while emphasizing that chronic disease eventually leads to a common end-stage involving all components. The discussion highlights critical clinical markers such as azotemia and uremia, distinguishing between the inflammatory presentations of nephritic syndrome—characterized by hematuria and hypertension—and the permeability defects of nephrotic syndrome, which result in massive proteinuria and edema. Detailed analysis is provided for immune-mediated glomerular injury, covering the role of circulating complexes, in situ antibody binding, and complement pathway activation. Key clinical entities including minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy are framed as various forms of podocytopathy, where damage to visceral epithelial cells and slit diaphragms disrupts the filtration barrier. The chapter further examines tubulointerstitial diseases, such as acute pyelonephritis and drug-induced hypersensitivity reactions, alongside the hemodynamic and toxic triggers of acute tubular injury. Vascular pathologies like nephrosclerosis and the microangiopathic processes of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura are contextualized within the broader framework of renal failure. Furthermore, the text addresses the genetic underpinnings of ciliopathies like polycystic kidney disease and the molecular oncology of renal cell carcinoma, particularly the influence of the VHL and MET genes. Ultimately, this overview provides students and practitioners with a robust understanding of the histopathological transitions from acute injury to irreversible fibrotic scarring and end-stage kidney disease.